FIELD: medicine. SUBSTANCE: method involves applying transesophageal electric cardiac stimulation in anterograde conduction of excitation through atria. Transesophageal electric cardiac stimulation frequency is set 50% higher than the basic sinus rhythm. More than 9% of anterograde conduction of excitation together with two or more atrium wall hypo- or akinesia areas being developed before and after stimulation, atrial fibrillation and flutter paroxysm development is predicted. EFFECT: high accuracy of prognosis. 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING RELAPSES OF FIRSTLY APPEARED PAROXYSMS OF ATRIAL FIBRILLATION | 1999 |
|
RU2192775C2 |
| METHOD FOR PREDICTING PAROXYSMS OF AURICULAR FIBRILLATION | 2000 |
|
RU2195872C2 |
| METHOD FOR PREVENTING ATRIAL FIBRILLATION AND FLUTTER PAROXYSMS | 2002 |
|
RU2219975C2 |
| METHOD FOR PREVENTING FLUTTER AND FIBRILLATION PAROXYSMS DEVELOPMENT IN ATRIA BEING REFRACTORY TO PHARMACEUTICAL ANTIARRHYTHMIA THERAPY | 2004 |
|
RU2268079C1 |
| METHOD FOR DETECTING EFFICIENCY OF MODULATED KINESITHERAPY | 2005 |
|
RU2286086C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF PAROXYSMS OF ATRIAL FLUTTER AND FIBRILLATION IN PATIENTS AT SUPRAVENTRICULAR EXTRASYSTOLIA | 2005 |
|
RU2294137C2 |
| METHOD FOR PREDICTING ATRIAL FIBRILLATION OR FLUTTER PAROXYSM PROGRESSIVE DEVELOPMENT IN SUPRAVENTRICULAR EXTRASYSTOLE PATIENTS | 2006 |
|
RU2303390C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF ATRIAL PAROXYSMS OF FLUTTER AND FIBRILLATION IN PATIENTS WITH SUPRAGASTRIC EXTRASYSTOLIA | 2006 |
|
RU2312592C1 |
| METHOD FOR SELECTING ANTIRECIDIVATION THERAPY OF THE FIBRILLATION PAROXYSMS AND ATRIAL FLUTTER ARISEN FOR THE FIRST TIME | 1999 |
|
RU2192776C2 |
| METHOD FOR DETERMINING ELECTROPHYSIOLOGICAL MECHANISMS OF EXTRASYSTOLIA DEVELOPMENT | 1998 |
|
RU2214161C2 |
